Last updated: May 6, 2026

Cat Injection Site Sarcoma (FISS): Causes, Prevention & Treatment

Vaccinations are one of the most effective tools in feline preventive medicine. They protect cats from deadly diseases like rabies, feline distemper, and feline leukemia. But in a small number of cats, the very injections designed to protect them can trigger an unexpected and dangerous complication: a malignant tumor at the injection site. This condition, formally known as feline injection site sarcoma, has reshaped how veterinarians approach vaccination protocols, injection techniques, and long-term monitoring.

If you are a cat owner — whether you have just adopted your first rescue or have cared for felines for decades — understanding cat injection site sarcoma is an important part of responsible pet ownership. This guide explains what FISS is, what causes it, how to recognize it, and what to do if you find a suspicious lump on your cat.

What Is Cat Injection Site Sarcoma?

Cat injection site sarcoma is a type of malignant soft tissue tumor — specifically a fibrosarcoma — that develops at or near the location where a cat has received a subcutaneous or intramuscular injection. These tumors are aggressive, locally invasive, and have a significant tendency to recur after surgical removal. Unlike many cancers that take years to develop, FISS tumors can appear anywhere from several months to several years after the injection that triggered the inflammatory response.

The condition was first identified in the early 1990s when veterinary pathologists noticed a dramatic increase in fibrosarcomas occurring in the interscapular region — the area between a cat’s shoulder blades — which was the standard injection site for rabies and feline leukemia virus (FeLV) vaccines at the time. The correlation between the tumor location and injection site was strong enough to prompt widespread changes in veterinary practice.

FISS tumors differ from other feline soft tissue tumors in important ways. They tend to be more aggressive, grow more rapidly, and send finger-like projections of tumor cells deep into surrounding tissue. This invasive growth pattern is the primary reason these tumors are so difficult to eliminate completely and have such high recurrence rates — reported between 30 and 70 percent depending on the aggressiveness of initial surgery.

What Causes Feline Injection Site Sarcoma?

The exact mechanism behind cat injection site sarcoma is not fully understood, but the prevailing theory centers on chronic inflammation. When a cat receives an injection, the body mounts a localized inflammatory response to the foreign material — the vaccine, the adjuvant (an ingredient added to enhance immune response), or even the needle itself. In most cats, this inflammation resolves normally. In a small number of genetically predisposed cats, however, the persistent inflammation triggers abnormal cell growth that eventually becomes cancerous.

Adjuvanted vaccines were initially considered the primary culprit. Aluminum-based adjuvants, which are added to killed (inactivated) vaccines to boost immune response, cause a more intense and prolonged inflammatory reaction at the injection site. Studies in the 1990s found aluminum deposits within FISS tumors, which strengthened the link between adjuvanted vaccines and tumor development. This led to a significant push toward non-adjuvanted vaccine formulations.

However, FISS has also been documented at sites where non-adjuvanted vaccines, long-acting antibiotics, corticosteroids, lufenuron (a flea prevention product), and even microchips were administered. This strongly suggests that the trigger is not limited to one specific substance but rather the inflammatory process itself. Any injection that causes chronic local inflammation has the theoretical potential to initiate tumor development in a susceptible cat.

Genetic predisposition plays a role. Researchers have identified mutations in the p53 tumor suppressor gene within FISS tumors, suggesting that certain cats may have an inherent vulnerability to this type of cancer. The fact that only a tiny fraction of vaccinated cats develop FISS while millions are vaccinated safely each year supports the theory that individual genetic factors determine susceptibility.

Risk Factors for Cat Injection Site Sarcoma

While any cat that receives injections is theoretically at risk, certain factors appear to increase the likelihood of FISS development.

Number of injections at the same site: Cats that receive multiple injections in the same anatomical location over time face a higher cumulative risk. Each injection restarts the inflammatory cycle, and repeated inflammation at the same site may increase the chance of malignant transformation.

Type of vaccine or injectable: Killed (adjuvanted) vaccines — particularly older rabies and FeLV formulations — have been most frequently associated with FISS. However, as noted above, non-adjuvanted products and non-vaccine injectables have also been implicated.

Temperature of the injectable: Some research suggests that cold vaccines administered directly from the refrigerator without warming may provoke a stronger local inflammatory response than room-temperature preparations, although this remains an area of ongoing study.

Individual immune response: Cats with more robust or dysregulated inflammatory responses at injection sites may be at higher risk. There is currently no commercially available test to predict which cats will develop FISS.

Signs and Symptoms of FISS

Early detection of cat injection site sarcoma dramatically improves treatment outcomes. Every cat owner should know what to look for, especially in the weeks, months, and years following any injection.

A lump at a previous injection site: The most common sign is a firm, painless mass at or near a location where the cat has previously received an injection. This is the hallmark presentation. Not every post-vaccine lump is a sarcoma — small, transient swellings are common after vaccinations and typically resolve within two to four weeks. It is when a lump persists, grows, or reappears that concern should escalate.

The 3-2-1 rule: Veterinary oncologists have developed a practical guideline known as the 3-2-1 rule to help cat owners and general practitioners decide when a post-injection lump warrants a biopsy. A lump should be investigated further if it:

• Is still present 3 months after the injection
• Is larger than 2 centimeters in diameter
• Is growing 1 month or more after the injection

If any one of these criteria is met, a biopsy — not just monitoring — is recommended. Waiting too long allows the tumor to grow deeper and wider, making surgical cure significantly more difficult.

Additional symptoms: As the tumor grows, the cat may show signs of discomfort or stiffness in the affected area, reluctance to be touched or picked up, lethargy, or weight loss. In advanced cases where the tumor has metastasized (spread to other parts of the body, most commonly the lungs), respiratory symptoms such as coughing or labored breathing may develop.

How Is Cat Injection Site Sarcoma Diagnosed?

If a suspicious lump is identified, the diagnostic process typically involves several steps.

Physical examination: Your veterinarian will assess the size, shape, firmness, and mobility of the mass. FISS tumors tend to be firm and poorly mobile — they feel as though they are attached to deeper tissues rather than rolling freely under the skin.

Fine-needle aspirate (FNA): A needle is inserted into the mass to collect cells for microscopic examination. While FNA can sometimes identify tumor cells, it is not always reliable for FISS because these tumors can have regions of inflammation and necrosis that may not yield diagnostic cells. A negative FNA does not rule out sarcoma.

Incisional biopsy: A small tissue sample is surgically removed and sent to a veterinary pathologist. This is the gold standard for confirming a FISS diagnosis and determining the tumor grade. An incisional biopsy — rather than an excisional biopsy — is preferred initially because it provides diagnostic information without compromising the surgical margins that will be needed if radical excision follows.

Advanced imaging: Before surgery, CT (computed tomography) scans or MRI are strongly recommended to determine the full extent of the tumor. FISS tumors frequently extend far beyond what can be felt on physical examination, sending microscopic tendrils of tumor cells several centimeters into surrounding tissue. Imaging helps the surgeon plan the wide margins necessary for the best chance of complete removal.

Chest X-rays or CT: Because FISS can metastasize to the lungs, thoracic imaging is performed before surgery to check for spread. If metastasis is already present, the treatment plan and prognosis change significantly.

Treatment Options for Feline Injection Site Sarcoma

Treatment for cat injection site sarcoma typically involves one or more of the following approaches. The best outcomes result from an aggressive, multimodal strategy coordinated by a veterinary oncologist.

Radical surgical excision: Surgery is the cornerstone of FISS treatment. Because of the tumor’s invasive growth pattern, wide surgical margins — a minimum of 3 to 5 centimeters on all sides and at least one fascial plane deep — are necessary. This is significantly more tissue than is removed in typical lump removals, which is why FISS surgery is considered a major procedure. When the tumor is located on a limb (a result of modern vaccination site guidelines, discussed below), amputation may provide the cleanest margins and the best chance of preventing recurrence. Cats adapt remarkably well to three-legged life.

Radiation therapy: Radiation is often used in combination with surgery — either before surgery (to shrink the tumor and improve surgical margins) or after surgery (to destroy any remaining microscopic tumor cells). Pre-operative radiation has shown promising results in some studies, reducing recurrence rates when combined with aggressive surgery.

Chemotherapy: The role of chemotherapy in FISS treatment is still being studied. Doxorubicin and carboplatin are the agents most commonly used. While chemotherapy alone is not curative for FISS, it may help slow tumor growth, reduce metastasis risk, and extend survival time when combined with surgery and radiation.

Immunotherapy and newer approaches: Ongoing research into feline oncology includes investigations of immunotherapy, electrochemotherapy, and targeted molecular therapies. While none of these have replaced surgery as the primary treatment, they represent promising areas of future development.

Prognosis: The prognosis for FISS depends heavily on the size of the tumor at diagnosis, whether it has metastasized, and how aggressively it is treated. Cats that undergo radical first surgery with clean margins have the best outcomes, with median survival times of two to four years or more. Cats whose tumors recur after incomplete surgery face a more challenging prognosis, as recurrent tumors tend to be more aggressive and harder to remove completely. This is why the initial surgery is so important — and why owners should seek a veterinary surgeon or oncologist experienced with FISS rather than relying on a simple lumpectomy.

Prevention: How to Reduce the Risk of FISS

While there is no guaranteed way to prevent cat injection site sarcoma, veterinary medicine has adopted several strategies to minimize the risk and improve outcomes when tumors do develop.

Updated vaccination site guidelines: The Vaccine-Associated Feline Sarcoma Task Force (VAFSTF) — now part of broader veterinary advisory groups — recommended moving injection sites away from the interscapular region to specific limb locations. Rabies vaccines are now typically given in the right rear leg, FeLV vaccines in the left rear leg, and FVRCP (distemper combination) vaccines in the right front leg. The reasoning: if a sarcoma does develop on a limb, amputation offers a much better chance of complete tumor removal than surgery between the shoulder blades, where the tumor can invade the spine and chest wall.

Non-adjuvanted vaccines: Whenever possible, veterinarians now recommend non-adjuvanted or recombinant vaccine formulations to reduce the intensity of the local inflammatory response. PureVax (recombinant rabies vaccine) is one widely used example. While non-adjuvanted vaccines do not eliminate FISS risk entirely, they appear to reduce it.

Tailored vaccination schedules: Not every cat needs every vaccine every year. Current veterinary guidelines recommend core vaccines (rabies and FVRCP) at appropriate intervals — typically every three years for adult cats after the initial series — and lifestyle-based decisions about non-core vaccines like FeLV. Reducing the total number of injections a cat receives over its lifetime reduces cumulative risk. Discuss your cat’s specific needs with your veterinarian. If you are adopting a cat and want to understand their vaccination history, your adoption counselor or shelter veterinarian can help clarify what has already been given and what is still needed.

Proper injection technique: Administering vaccines subcutaneously (under the skin) rather than intramuscularly, using the smallest appropriate needle, and avoiding repeated injections at the exact same spot all contribute to risk reduction.

Monitor injection sites: After any vaccination or injection, make a habit of gently feeling the injection site every few weeks. Familiarity with your cat’s normal body contours makes it far easier to detect a new or growing lump early — when treatment is most likely to succeed.

Should You Still Vaccinate Your Cat?

Absolutely. The risk of a cat dying from a preventable disease like rabies, panleukopenia, or feline leukemia is far greater than the risk of developing injection site sarcoma. FISS is rare — the diseases that vaccines prevent are not. Skipping vaccinations exposes your cat to serious, often fatal illnesses and, in the case of rabies, creates a public health concern as well.

The answer is not to avoid vaccination but to vaccinate thoughtfully. Work with your veterinarian to develop a vaccination plan that provides necessary protection without unnecessary injections. Use non-adjuvanted products when available. Follow updated injection site guidelines. And monitor your cat’s injection sites regularly so that if a problem does arise, it is caught as early as possible.

Understanding the breeds you share your home with can also help you make informed health decisions. Our cat breeds directory provides detailed profiles that cover breed-specific health considerations, temperament, and care needs — all useful context when discussing preventive care with your veterinarian.

Living with a Cat Diagnosed with FISS

A FISS diagnosis is frightening, but it is not an automatic death sentence. Many cats go on to live comfortable, happy lives after treatment — especially when the tumor is caught early and treated aggressively. Here is what to expect.

Follow-up is essential. After surgery, your veterinarian or oncologist will schedule regular recheck appointments — typically every two to three months for the first two years — to monitor the surgical site for recurrence and check the lungs for metastasis. Do not skip these appointments.

Quality of life remains the priority. If your cat undergoes limb amputation, know that most cats adapt within days to weeks and return to normal activity levels. If chemotherapy or radiation is part of the plan, your veterinary team will monitor for side effects and adjust treatment to maintain your cat’s comfort and well-being.

Emotional support matters. A cancer diagnosis in a beloved pet is emotionally taxing. Lean on your veterinary team for honest guidance, ask questions, and seek support from pet owner communities or counseling resources if you need them.

Frequently Asked Questions

How common is cat injection site sarcoma?

FISS is considered rare. Estimates vary, but the most commonly cited range is approximately 1 in 1,000 to 1 in 10,000 vaccinated cats. The incidence may be declining as veterinary practices adopt non-adjuvanted vaccines, updated injection site protocols, and more conservative vaccination schedules. However, because millions of cats are vaccinated each year, even a low incidence rate means a meaningful number of cats are affected annually.

Can cat injection site sarcoma be cured?

Cure is possible, particularly when the tumor is detected early, is small at the time of diagnosis, and is treated with radical surgical excision achieving clean margins on all sides. Some cats remain tumor-free for years after surgery. However, FISS has a high local recurrence rate — 30 to 70 percent in some studies — especially when initial surgery does not achieve wide enough margins. This is why the quality of the first surgery is so critical and why referral to a veterinary oncologist or surgical specialist is strongly recommended.

How long after a vaccination can FISS develop?

FISS tumors typically develop between three months and several years after the triggering injection. The median time from vaccination to tumor detection varies across studies but is generally reported as six months to three years. Some cases have been documented even longer after the last known injection at that site. This extended timeline is one reason regular monitoring of previous injection sites is so important — you should not assume a site is “safe” simply because several months have passed without a lump.

Are certain cat breeds more prone to injection site sarcoma?

There is currently no strong evidence that any specific breed is significantly more or less susceptible to FISS than others. The condition has been reported across all breeds, mixed-breed cats included. The primary risk factors appear to be related to the type and number of injections, the individual cat’s inflammatory and genetic response, and the injection site location rather than breed. That said, research into genetic predisposition is ongoing, and future studies may identify breed-related risk variations.

My cat has a small lump after a vaccine — should I be worried?

Small, soft lumps at vaccination sites are common and usually represent a normal inflammatory response. Most resolve on their own within two to four weeks. You should become concerned — and contact your veterinarian — if the lump is still present three months after the injection, is larger than two centimeters in diameter, or is growing one month or more after the injection (the 3-2-1 rule). Do not adopt a “wait and see” approach beyond these thresholds. Early biopsy and early treatment, if needed, offer the best chance of a positive outcome.

Should I switch to non-adjuvanted vaccines for my cat?

Discussing vaccine formulation with your veterinarian is a reasonable and responsible step. Non-adjuvanted and recombinant vaccines are associated with less intense local inflammatory reactions and may reduce FISS risk. Many veterinary clinics have already transitioned to non-adjuvanted products for cats as standard practice. However, not all vaccines are available in non-adjuvanted formulations, and the decision should be made in consultation with your vet based on your cat’s health status, lifestyle, and risk factors.